Team Members

Our Leadership Team

Experience building and leading cutting-edge medical device and biotech companies from concept to clinic.

United by a commitment to patient-centric innovation.

Ryan Neely, Ph.D.

CEO

Experience leading teams developing novel neural interfaces, AI-driven cancer drug discovery, and next-generation wearables.

Josh Kay

CTO

Brings deep expertise in bioelectronic devices and wireless body area networks, from novel R&D to production.

Andrew Bohannon, Ph.D.

CSO

Brings broad scientific expertise and experience leading development of regulated medical devices from concept to clinic.

World-Class Cardio-Oncology Advisory Board

Anne Blaes, M.D.

Professor, Hematology and Oncology, University of Minnesota; Director, Cancer Prevention and Control Program, Masonic Cancer Center

Christine Brezden-Masley, M.D.

Medical Director, Cancer Program at Sinai Health, Professor, Temerty Medicine, University of Toronto, Toronto Canada

Susan Dent, M.D.

Susan Dent, M.D. Director, Cardio-Oncology Program, and Judy DiMarzo Cancer Institute Survivorship Program, University of Rochester

Michael Fradley, M.D.

Section Chief, Consultive Cardiology and Assistant Professor of Medicine, U Penn; Medical Director, Thalheimer Center for Cardio-Oncology; President, International Cardio Oncology Society

Joshua Mitchell, M.D.

Associate Professor of Medicine Director, Cardio-Oncology Center of Excelence Director, Cardio-Oncology Felowship Co-Director, Amyloid Center of Excelence, Washington University in St. Louis

Javid Moslehi, M.D.

William Grossman Distinguished Professor in Cardiology Section Chief, Cardio-Oncology & Immunology Professor in Residence, UCSF School of Medicine, Department of Medicine, Division of Cardiology Cardiovascular Research Institute (CVRI)

Eric H. Yang, M.D.

Clinical Professor of Medicine Director, UCLA Cardio-Oncology Program Division of Cardiology, Department of Medicine University of California, Los Angeles

Han Zhu, M.D.

Assistant professor of Medicine, Stanford University and Director, Stanford Translational Cardio-Oncology

Partner With Us

Interested in clinical trial collaborations, cardiac safety monitoring,

or digital biomarker development?